Amalgamated Bank’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Hold |
1,269
| – | – | ﹤0.01% | 1652 |
|
|
2025
Q1 | $148K | Buy |
1,269
+17
| +1% | +$1.98K | ﹤0.01% | 1599 |
|
|
2024
Q4 | $106K | Hold |
1,252
| – | – | ﹤0.01% | 1691 |
|
|
2024
Q3 | $113K | Hold |
1,252
| – | – | ﹤0.01% | 1688 |
|
|
2024
Q2 | $101K | Buy |
1,252
+36
| +3% | +$2.9K | ﹤0.01% | 1707 |
|
|
2024
Q1 | $97K | Sell |
1,216
-3,874
| -76% | -$309K | ﹤0.01% | 1729 |
|
|
2023
Q4 | $405K | Sell |
5,090
-139
| -3% | -$11.1K | ﹤0.01% | 1520 |
|
|
2023
Q3 | $365K | Buy |
5,229
+257
| +5% | +$17.9K | ﹤0.01% | 1556 |
|
|
2023
Q2 | $357K | Buy |
4,972
+443
| +10% | +$31.8K | ﹤0.01% | 1590 |
|
|
2023
Q1 | $279K | Sell |
4,529
-750
| -14% | -$46.2K | ﹤0.01% | 1671 |
|
|
2022
Q4 | $407K | Buy |
5,279
+467
| +10% | +$36K | ﹤0.01% | 1559 |
|
|
2022
Q3 | $215K | Buy |
4,812
+261
| +6% | +$11.7K | ﹤0.01% | 1817 |
|
|
2022
Q2 | $174K | Buy |
4,551
+26
| +0.6% | +$994 | ﹤0.01% | 1934 |
|
|
2022
Q1 | $187K | Buy |
+4,525
| New | +$187K | ﹤0.01% | 1967 |
|
|
2021
Q3 | – | Sell |
-5,248
| Closed | -$354K | – | 2165 |
|
|
2021
Q2 | $354K | Buy |
5,248
+1,308
| +33% | +$88.2K | ﹤0.01% | 1805 |
|
|
2021
Q1 | $223K | Sell |
3,940
-392
| -9% | -$22.2K | 0.01% | 1430 |
|
|
2020
Q4 | $353K | Buy |
4,332
+22
| +0.5% | +$1.79K | 0.01% | 1143 |
|
|
2020
Q3 | $307K | Sell |
4,310
-123
| -3% | -$8.76K | 0.01% | 1100 |
|
|
2020
Q2 | $365K | Sell |
4,433
-202
| -4% | -$16.6K | 0.02% | 1000 |
|
|
2020
Q1 | $273K | Buy |
4,635
+47
| +1% | +$2.77K | 0.01% | 1194 |
|
|
2019
Q4 | $474K | Buy |
+4,588
| New | +$474K | 0.01% | 1145 |
|